The neonatal (PND 7) lesion of the ventral hippocampus (VH) with ibotenic acid represents a well-established experimental paradigm that recapitulates many schizophrenia-like phenomena. In order to investigate molecular changes that could contribute to long lasting consequences on brain function, we have investigated the effects of the VH lesion on the expression for the trophic factors FGF-2 and BDNF. We used RNase protection assay to measure their mRNA levels in cortical regions of prepubertal (PND 35) and young adult (PND 56) animals, both under basal condition as well as in response to an acute restraint stress. The expression of BDNF was not altered by the VH lesion in prefrontal (PFC) and frontal cortex (FC) of PND 35 or PND 56 rats. An acute restraint stress at PND 35 produced a significant increase of the neurotrophin expression in PFC of sham as well as lesioned animals. However in young adult animals a significant elevation of BDNF expression was observed only in sham rats. We also found that the VH lesion produced a significant reduction of basal BDNF mRNA levels in the cingulate cortex of young adult, but not prepubertal rats. This effect was not accompanied by changes in the acute modulation of the neurotrophin, which was up-regulated by stress in both experimental groups. Conversely the expression of FGF-2 at PND 35 and PND 56 was not altered by early postnatal VH lesion, and there were no major differences between sham and lesioned animals in response to the acute stress. The changes in trophic factor expression may be relevant for the long-term effects of VH lesion on synaptic plasticity and may determine an increased vulnerability of the brain under challenging situations. Molecular Psychiatry (2001) 6, 285-292.
Introduction
Schizophrenia is a complex disorder characterized by hallucinations, delusions, cognitive deficits and dramatic functional impairment. The neurodevelopmental hypothesis of schizophrenia provides a starting point to understand structural and functional abnormalities which have been observed in the brain of schizophrenic patients, particularly at the level of prefrontal cortex and hippocampal formation. [1] [2] [3] In vivo imaging and postmortem studies on schizophrenic subjects have demonstrated the presence of neuropathological abnormalities in the hippocampus that may correlate with the deficits in episodic memory, a form of explicit memory linked to hippocampal function. 4, 5 Such abnormalities may be the result of alterations in brain development, probably occurring Correspondence: MA Riva, Center for Neuropharmacology, Via Balzaretti 9, 20133 Milan, Italy. E-mail: marivaȰmailserver. unimi.it Received 21 September 2000; revised and accepted 27 November 2000 during early stages of gestation, that will affect the function of prefrontal-intracortical connectivity. [6] [7] [8] [9] Although several factors can contribute to cortical maldevelopment, one possibility is the involvement of neurotrophic factors. 10 These proteins are important regulators of brain development and neuronal shaping and play a role in synaptic plasticity as well as in the maintenance of cellular homeostasis. [11] [12] [13] [14] [15] There is a characteristic temporal and spatial pattern of expression for these molecules during brain development. 16, 17 Abnormalities in their expression profiles during development may affect the functional connectivity of specific neuronal phenotypes that become evident after the brain has reached full maturation. For example the lack of FGF-2 signaling in FGF-2-deficient mice affects migration of a fraction of neuronal precursor during cerebral cortex development 18 and reduces the number of cortical neurons and glial cells at maturity. 19 Because of the importance of growth factors for the cortical abnormalities implicated in schizophrenia, we studied the expression profile of brain-derived neurotrophic factor (BDNF) and fibroblast growth factor-2 (FGF-2) in a developmental animal model of schizophrenia.
BDNF, a member of the neurotrophin family, has a wide distribution in the CNS, where it is synthesized predominantly by neurons and is highly expressed in hippocampus, cerebral cortex, limbic areas and cerebellum. 20, 21 This neurotrophin plays an important role in regulating the survival and differentiation of selective populations of neurons during development 22, 23 and is an important mediator of neuronal adaptive responses. [12] [13] [14] The expression of BDNF is regulated by neuronal activity, shows marked and transient changes in response to a number of neuronal insults, including ischemia, hypoglycemia, epileptic activity, immobilization stress and trauma 17, [24] [25] [26] [27] [28] and its modulation involves a complex interplay between different neurotransmitter systems. 29, 30 FGF-2 is a trophic molecule that has a critical role in the maturation and survival of a variety of neuronal phenotypes. 15, 31 Its expression is regulated by neuronal activity, 32, 33 neurotransmitters and hormones [34] [35] [36] as well as by learning and physical exercise. 37, 38 It is well established that FGF-2 has neuroprotective activity over a wide range of neurons [39] [40] [41] and it may render the cells more resistant to potential lethal damage. 42, 43 The animal model employed in our study is obtained by bilateral infusion of the excitotoxin ibotenic acid in the ventral hippocampus (VH) of rats on the 7th day of age 44 and reproduces some fundamental features of schizophrenia, including dopaminergic overactivity and emergence of behavioral abnormalities in early adulthood. Adult rats with the neonatal VH lesion express exaggerated locomotor response to amphetamine and to acute stress, 44 augmented apomorphineinduced stereotypy, 45 and altered prepulse inhibition of the acoustic startle response. 46 Moreover, the expression of behavioral phenotypes is strain-dependent. 47 Neonatal damage of the hippocampus also disrupts complex behaviors such as working memory and social interaction. 48 Some of these behavioral abnormalities are reversed by treatment with typical and atypical antipsychotics. 49 Using this paradigm, we have analyzed the expression profile of BDNF and FGF-2 in prefrontal, frontal and cingulate cortex in prepubertal and mature animals. Since an impairment in coping with specific challenging situations may represent a long-lasting effect observed after the lesion as well as other developmental perturbations, 50 we have also investigated whether the stress-dependent regulatory mechanism of neurotrophic factor expression 27, 28, 35 could be altered as a consequence of the neonatal hippocampal lesion.
Materials and methods

Materials
General reagents were purchased from Sigma (Milan, Italy), whereas molecular biology reagents were obtained from Ambion (Austin, TX, USA), New England Biolabs (Beverly, MA, USA) and Promega (Milan, Italy).
Surgery
Rat pups were lesioned as described previously. 48 Briefly, pregnant Sprague-Dawley rats obtained at 12-14 days of gestation (Harlan, Indianapolis, IN, USA) were housed individually in breeding cages with a 12-h light/dark cycle and fed ad libitum. Litters of four to eight male pups were formed. On the 7th day of age (PND 7) pups (weight 15-18 g), within each litter were randomized to Sham or Lesion status and anaesthetized by hypothermia (placed on ice for 15-20 min). An incision was made in the skin overlying the skull and 0.3 l of 10 g l −1 of ibotenic acid solution (in the lesioned rats) or artificial cerebrospinal fluid (in shamoperated rats) was infused bilaterally, through a Hamilton needle, using an infusion pump into the ventral hippocampal formation (AP −3.0 mm, ML ± 3.5 mm, VD −5.0 mm, relative to Bregma) at the rate of 0.15 l min . The pups were warmed and then returned to their mothers. On the 25th day of age rats were weaned, separated according to the lesion status and grouped two to a cage.
Experimental procedure
The effect of the neonatal VH ibotenic acid lesion on neurotrophic gene expression as well as the effect of acute stress in sham and lesion animals was assessed at PND 35 (before puberty) and PND 56 (after puberty). Rats were randomly assigned to four groups (Sham/No Stress; Sham/Stress; Lesion/No Stress; Lesion/Stress). The animals undergoing restraint stress were placed for 2 h in transparent plexiglas containers whereas those in the control group were left undisturbed in their home cages. Rats were killed by decapitation 1 h after the end of immobilization, their brains rapidly removed and the following cortical regions were dissected from 2-mm thick slices: prefrontal cortex PFC (defined as Cg1, Cg3 and IL subregions corresponding to the plates 6-9 according to the atlas of Paxinos and Watson, 51 frontal cortex FC (comprising regions Fr1-3, Par1 and AI from the same slice as PFC) and cingulate cortex CC (comprising Cg1 and Cg3 areas from the slice corresponding to plates 10-13 in the atlas of Paxinos and Watson. 51 We have investigated PFC and CC, as compared to FC, because they are connected with the hippocampal formation (that is lesioned in our paradigm) and because functional 1 and anatomical 52 changes have been detected at this level in schizophrenic subjects. All the specimens were frozen on dry ice and stored at −80°C for further analysis.
RNA preparation
The tissue was homogenized in 4 M guanidinium isothiocyanate (containing 25 mM sodium citrate pH 7.5, 0.5% sarcosyl and 0.1% 2-mercaptoethanol) and total RNA was isolated by phenol-chloroform extraction. 53 Quantification was carried out by spectrophotometric analysis and RNA aliquots were re-precipitated in ethanol for RNase protection assay.
RNA probes synthesis for RNase protection assay
A transcription kit (MAXI script, Ambion) was used to generate cRNA probes and 32 P-CTP was used as a radiolabelled nucleotide. The following plasmids were employed in the RNase protection assay: plasmid pSKrB(C1), containing rat BDNF coding region, was linearized with Xma I and used to generate a 32 P-labeled 800-bases antisense cRNA probe, which included 740 of BDNF sequence and 60 bases of the polylinker region; plasmid RobFGF103, containing rat FGF-2 coding region, was linearized with Nco I and used to generate a 32 P-labeled 524-bases antisense cRNA probe, which included 477 of FGF-2 sequence and 47 bases of the polylinker region. A cRNA probe to glyceraldehyde 3-phosphate-dehydrogenase (GAPDH) was used as internal standard. By in vitro transcription with a T3 polymerase a 376-bases probe was obtained from the plasmid pTRI-GAPDH-Rat (Ambion) which, following RNase protection assay, yielded a protected fragment of 316 bases.
RNase protection assay
The RNase protection assay was performed on a 10-g sample of total RNA as described previously. 36 Briefly, after ethanol-precipitation total RNA, obtained from different tissues, was dissolved in 20 l of hybridization solution (80% formamide, 40 mM PIPES pH 6.4, 400 mM sodium acetate pH 6.4 and 1 mM EDTA) containing 150 000 cpm of BDNF and FGF-2 and 50 000 cpm of GAPDH 32 P-labeled cRNA probes (specific activity Ͼ10 8 cpm g −1 ). After being heated at 85°C for 10 min, the cRNA probes were allowed to hybridize the endogenous RNAs at 45°C overnight.
At the end of the hybridization, the solution was diluted with 200 l of RNase digestion buffer (300 mM NaCl, 10 mM Tris HCl pH 7.4, 5 mM EDTA pH 7.4) containing a 1/200 dilution of a RNase cocktail (1 mg ml −1 RNase A and 20 U ml −1 RNase T1) and incubated for 30 min at 30°C. Proteinase K (10 g) and SDS (10 l of 20% stock solution) were then added to the sample and the mixture was incubated at 37°C for an additional 15 min. At the end of the incubation the sample was extracted with phenol/chloroform and ethanol precipitated. The pellet, containing the RNA:RNA hybrids, was dried and resuspended in loading buffer (80% formamide, 0.1% xylene cyanol, 0.1% bromophenol blue, 2 mM EDTA), boiled at 95°C for 5 min and separated on a 5% polyacrylamide gel under denaturing conditions (7 M urea). The protected fragments were visualized by autoradiography.
RNA calculation and statistical analysis
The levels of mRNA for FGF-2, BDNF or GAPDH were calculated by measuring the peak densitometric area of the autoradiography analyzed with a LKB laser densitometer. In order to ensure that the autoradiographic bands were in the linear range of intensity, different exposure times were used. GAPDH was employed as internal standard for RNase protection assay: its expression was not altered by lesion or by stress. Because all within-age samples were processed on a Molecular Psychiatry single gel, optical densities from all within-age samples were analyzed separately. We analyzed by two-way analysis of variance (ANOVA) the data, with status (sham and lesion) and treatment (no stress and stress) as independent factors and BDNF or FGF-2 levels as dependent variables. When appropriate, further differences were analyzed by Single Contrast post-hoc test (SCPHT). Optical densities from experimental groups were then expressed and presented as mean percent of control values for graphic clarity. The mean percent represents the ratio between neurotrophic factor and GAPDH levels expressed as % of control (sham animals). The mean value of the control group within a single experiment was set to 100 and all other values were expressed as 'percent' of control animals.
Results
In order to investigate if changes in neurotrophic factor levels may represent a molecular consequence of the neonatal ibotenic acid lesion, the expression of BDNF and FGF-2 was assessed by RNase protection assay in prefrontal, frontal and cingulate cortex before and after puberty.
Basal BDNF mRNA levels were not altered by the neonatal VH lesion in prefrontal cortex (PFC) both at 35 and 56 PND (Figure 1 ). An acute restraint stress (2 h) produced a significant increase of BDNF expression before puberty (F 1,29 = 18.664, P = 0.002, two-way ANOVA). Although this increase was more pronounced in lesioned animals, single contrast post-hoc test (SCPHT) showed a significant effect of stress in sham (F 1,29 = 6.017, P = 0.042) as well as in lesion rats (F 1,29 = 12.858, P = 0.002). Conversely, we observed a significant effect of the lesion on stress-induced modification of BDNF mRNA levels in young adult animals. Although, at PND 56, there was a small increase in basal BDNF levels in PFC of lesioned rats, this was not significant with respect to sham animals (F 1,28 = 0.226, P = 0.639). However the induction of BDNF and mRNA expression after immobilization was significant in sham (F 1,28 = 8.356, P = 0.018; SCPHT) but not in lesioned animals (F 1,28 = 1.209, P = 0.284; SCPHT) (Figure 1 ), suggesting that at this age there is a reduced function of stress-dependent regulation of BDNF as consequence of the neonatal lesion.
In FC the lesion did not affect the basal expression of the neurotrophin at PND 35 or 56. The acute stress produced a reduction of BDNF mRNA levels at PND 35 (F 1,26 = 14.332, P = 0.0009; two-way ANOVA) which was significant only in lesioned rats (F 1,26 = 11.597, P = 0.004; SCPHT), without changing its expression in young adult animals ( Table 1) .
Despite no significant effects in PFC and FC, the VH lesion produced a significant reduction of BDNF expression in CC of young adult animals (F 1,28 = 9.144, P = 0.006; two-way ANOVA) but not at PND 35 (F 1,28 = 1.933, P = 0.181; two-way ANOVA) (Figures 2 and  3 ). We observed a slight, although not significant, reduction of BDNF after restraint stress in lesioned rats at PND 35, resembling the effect in FC. Conversely, as depicted in Figure 3 , BDNF mRNA levels were consistently up-regulated by immobilization in the CC at PND 56 both in sham (F 1,28 = 23.068, P = 0.00016; SCPHT) as well as lesioned rats (F 1,28 = 15.003, P = 0.0016; SCPHT). The analysis of FGF-2 indicates that its basal expression is not affected by the lesion before and after puberty in any cortical areas considered (Figures 4, 5 and Table 2 ). The acute restraint stress elicited a significant upregulation in PFC at PND 35 (F 1,29 = 9.333, P = 0.005; two-way ANOVA) as well as 56 (F 1,28 = 14.741, P = 0.0008; two-way ANOVA). The effect at PND 35 was significant in sham (F 1,28 = 9.201, P = 0.012; SCPHT) but not in lesioned animals (F 1,28 = 2.037, P = 0.34; SCPHT), whereas a similar increase at PND 56 was observed in sham (F 1,28 = 7.006, P = 0.028; SCPHT) and lesioned rats (F 1,28 = 7.748, P = 0.022; SCPHT) at adult age. The immobilization stress did not affect FGF-2 expression in FC of sham or lesion rats before and after puberty ( Table 2) . Conversely an elevation of FGF-2 expression was produced by stress in CC of young adult lesioned rats (F 1,28 = 7.026, P = 0.03; SCPHT), but not in sham operated animals (F 1,28 = 1.32, P = 0.263; SCPHT), as shown in Figure 5 . 
Discussion
The results of this study indicate that neonatal VH lesion, an animal model for schizophrenia-related dysfunction, reduces BDNF expression in adult CC and alters its stress-related modulation in PFC. According to its neurodevelopmental hypothesis, schizophrenia may be caused by subtle defects occurring in brain development, which disrupt late-maturing, highly evolved neocortical functions. [6] [7] [8] [9] Behavioral and functional abnormalities become fully manifest in adult life as a consequence of disturbance in processes that may involve neurotrophic factors. Hence the changes observed in the regulatory profile of BDNF and, to less extent, FGF-2 may represent one of the molecular events contributing to long-term impairment in brain function and plasticity.
The gene expression for BDNF was not altered by the VH lesion in prepubertal rats in cortical regions, but its expression was decreased in the CC of young adult rats. Postmortem studies provide some evidence for a decreased population of neuronal and glial cells, smaller clusters and increased numbers of inhibitory interneurons in the anterior cingulate cortex of schizophrenics. 52 It is known that the regulation of BDNF mRNA involves a complex interplay between different neurotransmitter systems, 30 GABA being inhibitory on neurotrophin expression. 29, 30 We could speculate that the selective reduction of BDNF levels observed in CC might be caused by an increased inhibitory tone, as a consequence of the neonatal VH lesion, becoming fully manifest only in adulthood.
Another consideration emerging from our studies is that the machinery controlling acute modulation of neurotrophic factors may be altered as a consequence of the neonatal lesion. It is known that the production of FGF-2 and BDNF in the adult CNS can be modulated under different circumstances. [24] [25] [26] [32] [33] [34] [35] [36] It is generally believed that these events represent adaptive mechanisms that, within the CNS, are important to cope with challenging situations. Functional changes of systems involved in the regulation of neurotrophic factor biosynthesis may increase CNS vulnerability to the potential damage brought about by different types of insults. It is known that stress affects neurotrophin gene expression with a precise anatomical profile. For example, 2 h of immobilization reduced BDNF mRNA levels in hippocampus 27 while increasing its expression in hypothalamus and pituitary gland. 28 Our data demonstrate that acute restraint stress increases BDNF mRNA levels in PFC of sham and lesion rats before puberty. However in young adult animals such effect is observed only in sham operated rats, suggesting that such regulatory mechanism is impaired as a consequence of the neonatal lesion. The temporal specificity of BDNF modulation by stress is in agreeMolecular Psychiatry ment with the delayed onset of behavioral abnormalities, displayed by neonatal lesioned rats only postpubertally, as well as with the evidence of prefrontal cortical cellular changes emerging in early adulthood. 54, 55 These effects might contribute to long-term alterations in brain plasticity. The lack of BDNF upregulation in this region may render the cells of PFC more vulnerable to the action of acute or prolonged stressors, which are thought to be important in exacerbating psychiatric symptoms. Indeed, stress-reduction strategies have significant impact in reducing relapserate of schizophrenics. 56 Such observations suggest that schizophrenia may develop when a threshold of stress tolerance is exceeded in a vulnerable individual. 57 Moreover, some schizophrenic patients are susceptible to relapse due to psychological stressors, even when maintained on antipsychotic medication. 58 The difference in the modulation of BDNF expression following stress might depend upon several mechanisms. It is known that stress not only increases the levels of circulating corticosteroids but also induces the release of several neurotransmitters. Glucocorticoid hormones are probably not responsible for BDNF modulation at this level, as they decrease rather than increase the production of the neurotrophin. 27 Dopamine might be a likely candidate, as it is well established that dopamine projections to the PFC are activated by stressful stimuli. 59 Previous studies have shown that, despite the fact that stress-induced locomotor activity is increased in VH lesioned rats, 44 these animals display reduced dopamine release. 60 Accordingly the lack of BDNF up-regulation in PFC after restraint stress may be related to a reduced dopaminergic response.
Glutamate is another neurotransmitter that is released in the PFC in response to stress 61 and may contribute to the up-regulation of BDNF. Glutamate, through its NMDA and non-NMDA receptors, stimulates BDNF transcription in cortex and hippocampus. 29 Accordingly, the lack of stress-induced modulation of BDNF levels in PFC may be the result of glutamatergic hypofunctionality, a situation that has been hypothesized in schizophrenia. 62, 63 It has been recently Figure 4 Effect of acute restraint stress on FGF-2 mRNA levels in prefrontal (PFC) of sham and lesion rats assessed at PND 35 and PND 56. The results, expressed as % of sham rats, represent the mean ± SEM of seven to eight samples for each experimental group. *P Ͻ 0.05 and **P Ͻ 0.01 vs control (non-stressed) rats (two-way ANOVA with SCPHT). observed that glutamate neurotransmission regulates stimulus-induced increase of dopamine release in prefrontal cortex. In particular, the activation of both NMDA and AMPA receptor subtypes in the ventral tegmental area as well as AMPA receptors in the PFC, contributes to dopamine release in the PFC in response to stress. 64 Hence it is possible to hypothesize that the abnormal regulation of BDNF expression in PFC after acute stress may be the result of a complex dysregulation involving dopaminergic as well as glutamatergic neurotransmission.
Although stress up-regulates BDNF expression also in young adult CC, we did not observe any significant difference between sham and VH lesioned rats, suggesting that in this region the neonatal lesion reduces the basal expression of the neurotrophin without altering its modulation by stress. The regulation of FGF-2 expression is somewhat different from BDNF. Our data indicate that the mRNA levels for FGF-2 in cortical regions are not altered following VH lesion. Furthermore its expression is upregulated in adult PFC in sham as well as in lesioned animals, suggesting that different mechanisms might be involved in the changes of BDNF and FGF-2 expression in response to stress. We may hypothesize that stress regulates FGF-2 expression through the elevation of glucocorticoid hormones as we have previously demonstrated that dexamethasone, a glucocorticoid analogue, increases FGF-2 mRNA levels in the rat brain. 35 In summary, we have shown that the VH lesion in developing rats may alter the basal expression of BDNF in young adult animals. Furthermore it appears that the stress-related mechanisms involved in the acute modulation of BDNF in PFC in adulthood might be altered as a consequence of the neonatal lesion. These data may help in understanding how stress or other challenging situations affect brain function in the context of neurodevelopmental injury. According to our results neurotrophic factors may represent potential molecular correlates of the long-term effects produced by deleterious events taking place during brain maturation. This possibility does not conflict with the well-characterized role of neurotransmitters in schizophrenia, since a sensitive balance between neurotransmitters and neurotrophic factors does exist. It is possible that altered activity of neurotransmitters, such as dopamine and glutamate, in PFC may be the expected consequence of neuronal maldevelopment. Neurotrophic factors may not only contribute to these developmental alterations but could represent molecular players for the alterations in synaptic plasticity under challenging situations.
